Literature DB >> 16565025

Bystander immune cytolysis.

Lawrence D Petz1.   

Abstract

In addition to alloimmune and autoimmune cell lysis, a third category of immune destruction of blood cells should be recognized. This additional immunologic response occurs when cells or tissues are injured by immunologic reactions in which the cells act as "innocent bystanders." One mechanism by which an immune response to an exogenous antigen leads to the destruction of autologous blood cells is the temporary development of autoantibodies. This is actually an alloimmune reaction which results in a temporary state of "pseudo"-autoimmunity. Although originally described as a type of hemolysis of autologous cells, the concept of bystander immune cytolysis has been extended to include other instances in which immune destruction of cells is caused by antibody that is not developed in response to intrinsic antigens on the cell being lysed. In recent years, compelling data have been presented documenting bystander immune cytolysis in a number of different clinical settings, and efforts have been made to define the mechanisms by which this occurs. Physicians must be aware that some examples of immune lysis of autologous cells are, in reality, examples of temporary bystander immune cytolysis rather than true autoimmune disease. Furthermore, some alloimmune hemolytic reactions can result in lysis of bystander cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565025     DOI: 10.1016/j.tmrv.2005.11.002

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  7 in total

1.  Hemolytic Transfusion Reactions.

Authors:  Erwin Strobel
Journal:  Transfus Med Hemother       Date:  2008-09-18       Impact factor: 3.747

2.  Hyperhaemolysis syndrome responsive to splenectomy in a patient with δβ-thalassaemia: a discussion on underlying mechanisms.

Authors:  Jose M Vagace; Maria S Casado; Roberto Bajo; Guillermo Gervasini
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

3.  HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.

Authors:  Marianne E McPherson; Alan R Anderson; Marta-Inés Castillejo; Christopher D Hillyer; Robert A Bray; Howard M Gebel; Cassandra D Josephson
Journal:  Pediatr Blood Cancer       Date:  2010-04       Impact factor: 3.167

4.  Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.

Authors:  Sarita Coleman; Connie M Westhoff; David F Friedman; Stella T Chou
Journal:  Transfusion       Date:  2019-04-25       Impact factor: 3.157

5.  American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

Authors:  Stella T Chou; Mouaz Alsawas; Ross M Fasano; Joshua J Field; Jeanne E Hendrickson; Jo Howard; Michelle Kameka; Janet L Kwiatkowski; France Pirenne; Patricia A Shi; Sean R Stowell; Swee Lay Thein; Connie M Westhoff; Trisha E Wong; Elie A Akl
Journal:  Blood Adv       Date:  2020-01-28

6.  An Attempt to Induce Transient Immunosuppression Pre-erythrocytapheresis in a Girl With Sickle Cell Disease, a History of Severe Delayed Hemolytic Transfusion Reactions and Need for Hip Prosthesis.

Authors:  Alessandro Cattoni; Giovanni Cazzaniga; Paolo Perseghin; Giovanni Zatti; Diego Gaddi; Andrea Cossio; Andrea Biondi; Paola Corti; Nicoletta Masera
Journal:  Hematol Rep       Date:  2013-06-28

7.  Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia.

Authors:  Zoe Bezirgiannidou; Anna Christoforidou; Eftychia Kontekaki; Athanasios G Anastasiadis; Spyros I Papamichos; Helen Menexidou; Dimitrios Margaritis; Georges Martinis; Elpis Mantadakis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-18       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.